Reccan AB

Reccan AB is a Swedish medtech company founded in 2014 that develops non-invasive blood tests to improve early detection of pancreatic cancer. Headquartered at Lund University Hospital, the firm addresses high mortality rates caused by late diagnoses and limited treatment options for this aggressive disease.

• Products: A unique, easy-to-use blood test designed for quick and accurate screening of pancreatic cancer.
• Industries: Focuses on medical technology and in vitro diagnostics to enhance clinical outcomes.
• History: Established by scientists including Professor Roland Andersson following extensive research into tumor biology and biomarkers at Lund University.

The company leverages over 500 international publications from its research group to validate its diagnostic approach, aiming to change the trajectory of cancer mortality through early diagnosis.